Soichiro Tajima

830 total citations
27 papers, 688 citations indexed

About

Soichiro Tajima is a scholar working on Hematology, Nephrology and Genetics. According to data from OpenAlex, Soichiro Tajima has authored 27 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Nephrology and 5 papers in Genetics. Recurrent topics in Soichiro Tajima's work include Iron Metabolism and Disorders (6 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). Soichiro Tajima is often cited by papers focused on Iron Metabolism and Disorders (6 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). Soichiro Tajima collaborates with scholars based in Japan and United Kingdom. Soichiro Tajima's co-authors include Keisuke Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki, Yasumasa Ikeda, Yoshitaka Kihira, Shuhei Tomita, Yuki Izawa‐Ishizawa, Yuya Horinouchi, Satohiro Masuda and Kazuyoshi Kawazoe and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and The FASEB Journal.

In The Last Decade

Soichiro Tajima

27 papers receiving 683 citations

Peers

Soichiro Tajima
Huihui Li China
P. Hopmeier Austria
Jerome L. Sullivan United States
Reny Joseph United States
Sherry Y. Hanson United States
Soichiro Tajima
Citations per year, relative to Soichiro Tajima Soichiro Tajima (= 1×) peers Yuya Horinouchi

Countries citing papers authored by Soichiro Tajima

Since Specialization
Citations

This map shows the geographic impact of Soichiro Tajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soichiro Tajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soichiro Tajima more than expected).

Fields of papers citing papers by Soichiro Tajima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soichiro Tajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soichiro Tajima. The network helps show where Soichiro Tajima may publish in the future.

Co-authorship network of co-authors of Soichiro Tajima

This figure shows the co-authorship network connecting the top 25 collaborators of Soichiro Tajima. A scholar is included among the top collaborators of Soichiro Tajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soichiro Tajima. Soichiro Tajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Mengyu, Soichiro Tajima, Kimitaka Suetsugu, et al.. (2022). Development and Validation of an LC-MS/MS Method to Quantify Gilteritinib and Its Clinical Application in Patients With FLT3 Mutation–Positive Acute Myelogenous Leukemia. Therapeutic Drug Monitoring. 44(4). 592–596. 2 indexed citations
2.
Tajima, Soichiro, Rao Fu, Mengyu Zhang, et al.. (2021). The mTOR inhibitor everolimus attenuates tacrolimus-induced renal interstitial fibrosis in rats. Life Sciences. 288. 120150–120150. 15 indexed citations
3.
Fu, Rao, Soichiro Tajima, Mengyu Zhang, et al.. (2021). Establishment of an experimental rat model of tacrolimus-induced kidney injury accompanied by interstitial fibrosis. Toxicology Letters. 341. 43–50. 8 indexed citations
4.
Tajima, Soichiro, et al.. (2019). Clinical prospects of biomarkers for the early detection and/or prediction of organ injury associated with pharmacotherapy. Biochemical Pharmacology. 170. 113664–113664. 31 indexed citations
5.
Suetsugu, Kimitaka, Soichiro Tajima, Hiroyuki Watanabe, et al.. (2019). Neutrophil Gelatinase-Associated Lipocalin Is Not Associated with Tacrolimus-Induced Acute Kidney Injury in Liver Transplant Patients Who Received Mycophenolate Mofetil with Delayed Introduction of Tacrolimus. International Journal of Molecular Sciences. 20(12). 3103–3103. 3 indexed citations
6.
Fu, Rao, Soichiro Tajima, Kimitaka Suetsugu, et al.. (2018). Biomarkers for individualized dosage adjustments in immunosuppressive therapy using calcineurin inhibitors after organ transplantation. Acta Pharmacologica Sinica. 40(2). 151–159. 27 indexed citations
7.
Kakiuchi, Soji, Soichiro Tajima, Yuya Horinouchi, et al.. (2015). Characteristics of and Risk Factors for Interstitial Lung Disease Induced by Chemotherapy for Lung Cancer. Annals of Pharmacotherapy. 49(4). 398–404. 38 indexed citations
8.
Ikeda, Yasumasa, Soichiro Tajima, Yuya Horinouchi, et al.. (2014). Iron Chelation by Deferoxamine Prevents Renal Interstitial Fibrosis in Mice with Unilateral Ureteral Obstruction. PLoS ONE. 9(2). e89355–e89355. 84 indexed citations
9.
Tajima, Soichiro, Yasumasa Ikeda, Yuya Horinouchi, et al.. (2014). Angiotensin II alters the expression of duodenal iron transporters, hepatic hepcidin, and body iron distribution in mice. European Journal of Nutrition. 54(5). 709–719. 22 indexed citations
10.
Ikeda, Yasumasa, Soichiro Tajima, Yuya Horinouchi, et al.. (2014). Ferritin induces IL‐1β production through inflammasome activation via NF‐κB‐dependent manner in macrophages (835.3). The FASEB Journal. 28(S1). 1 indexed citations
11.
Ikeda, Yasumasa, Soichiro Tajima, Yuki Izawa‐Ishizawa, et al.. (2013). Bovine Milk–derived Lactoferrin Exerts Proangiogenic Effects in an Src-Akt-eNOS–dependent Manner in Response to Ischemia. Journal of Cardiovascular Pharmacology. 61(5). 423–429. 15 indexed citations
12.
Ikeda, Yasumasa, Soichiro Tajima, Yuki Izawa‐Ishizawa, et al.. (2013). Dietary iron restriction inhibits progression of diabetic nephropathy indb/dbmice. American Journal of Physiology-Renal Physiology. 304(7). F1028–F1036. 46 indexed citations
13.
Ikeda, Yasumasa, Soichiro Tajima, Yuki Izawa‐Ishizawa, et al.. (2012). Estrogen Regulates Hepcidin Expression via GPR30-BMP6-Dependent Signaling in Hepatocytes. PLoS ONE. 7(7). e40465–e40465. 107 indexed citations
14.
Ikeda, Yasumasa, Ken‐ichi Aihara, Sumiko Yoshida, et al.. (2012). Heparin Cofactor II, a Serine Protease Inhibitor, Promotes Angiogenesis via Activation of the AMP-activated Protein Kinase-Endothelial Nitric-oxide Synthase Signaling Pathway. Journal of Biological Chemistry. 287(41). 34256–34263. 29 indexed citations
15.
Horinouchi, Yuya, Koichiro Tsuchiya, Soichiro Tajima, et al.. (2011). Antioxidant Effects of Photodegradation Product of Nifedipine. Chemical and Pharmaceutical Bulletin. 59(2). 208–214. 19 indexed citations
16.
Ikeda, Yasumasa, Soichiro Tajima, Sumiko Yoshida, et al.. (2011). Deferoxamine promotes angiogenesis via the activation of vascular endothelial cell function. Atherosclerosis. 215(2). 339–347. 63 indexed citations
17.
Tsuchiya, Koichiro, Yuya Horinouchi, Soichiro Tajima, et al.. (2011). Protective effect of photodegradation product of nifedipine against tumor necrosis factor alpha-induced oxidative stress in human glomerular endothelial cells. The Journal of Medical Investigation. 58(1,2). 118–126. 15 indexed citations
18.
Tajima, Soichiro, Koichiro Tsuchiya, Yuya Horinouchi, et al.. (2010). Effect of angiotensin II on iron-transporting protein expression and subsequent intracellular labile iron concentration in human glomerular endothelial cells. Hypertension Research. 33(7). 713–721. 23 indexed citations
19.
Ishizawa, Keisuke, Kunihisa Yamaguchi, Yuya Horinouchi, et al.. (2009). Drug Discovery for Overcoming Chronic Kidney Disease (CKD): Development of Drugs on Endothelial Cell Protection for Overcoming CKD. Journal of Pharmacological Sciences. 109(1). 14–19. 9 indexed citations
20.
Yamamoto, Akira, et al.. (1990). [Plasma lipoproteins: biochemistry and molecular pathology].. PubMed. 62(2). 89–112. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026